MedTrace Logo

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

NCT02296645 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2016-07-14

No results posted yet for this study

Summary

This is a randomized, paired-comparisons design where each subject receives two of the planned treatments.

Conditions

  • Surgical Site Infection

Interventions

DRUG

ZuraPrep

Apply topically.

DRUG

ChloraPrep

Apply topically.

Sponsors & Collaborators

  • Zurex Pharma, Inc.

    lead INDUSTRY

Principal Investigators

  • M. Hamid Bashir, MD · MicroBioTest, Division of Microbac Laboratories, Inc.

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02296645 on ClinicalTrials.gov